| Description | AUTHORS: Leo Heyndrickx5*, Alan Heath4, Enas Sheik-Khalil3, Jose Alcami1, Vera Bongertz2, Marianne Jansson6,
Mauro Malnati7, David Montefiori8, Christiane Moog9, Lynn Morris10, Saladin Osmanov11,
Victoria Polonis12, Meghna Ramaswamy4, Quentin Sattentau13, Monica Tolazzi14,
Hanneke Schuitemaker15, Betty Willems5, Terri Wrin16, Eva Maria Fenyo¨ 3, Gabriella Scarlatti14 --- AFFILIATIONS - Unidad de Immunopatologia del SIDA, Instituto de Salud Carlos III, Madrid, Spain, 2 Laboratory of AIDS and Molecular Immunology, Fundac¸a˜o Oswaldo Cruz, Rio de
Janeiro, Brazil, 3 Department of Laboratory Medicine, University of Lund, Lund, Sweden, 4 National Institute for Biological Standards and Control, Potters Bar,
Hertfordshire, United Kingdom, 5 Virology Unit, Biomedical Department, Institute of Tropical Medicine, Antwerp, Belgium, 6 Department of Microbiology, Tumor and Cell
Biology, Karolinska Institutet, Stockholm, Sweden, 7 Unit of Human Virology, San Raffaele Scientific Institute, Milan, Italy, 8 Duke University Medical Center, Durham, North
Carolina, United States of America, 9 Pathoge´nie des infections persistantes, University Louis Pasteur, Strasbourg, France, 10 National Institute for Communicable
Diseases, Johannesburg, South Africa, 11 WHO-UNAIDS HIV Vaccine Initiative, World Health Organization, Geneva, Switzerland, 12 Department of Vaccine Research, Henry
Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland, United States of America, 13 The Sir William Dunn School of Pathology, The University
of Oxford, Oxford, United Kingdom, 14 Viral Evolution and Transmission Unit, San Raffaele Scientific Institute, Milan, Italy, 15 Department of Experimental Immunology,
Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands, 16 Monogram Biosciences, San Francisco, California, United States of America. | pt_BR |
